Stock #13 Quarterly Update Q4FY25 – English

This hospital stock delivered a strong Q4, with over 30% revenue growth and steady profit numbers—but is the performance enough to justify its ambitious growth roadmap? With rising occupancy, improving ARPOB, and sequential profit momentum, the fundamentals look encouraging. But what really stands out is the company’s aggressive expansion—adding two new hospitals and targeting a doubling of capacity by FY27. Is this hospital stock quietly building a healthcare powerhouse, or are investors getting ahead of themselves? Watch now to understand the numbers, the risks, and the long-term story behind the stock.